No CrossRef data available.
Article contents
P0327 - Evaluation of the cardiovascular risk in patients with psychiatric pathology
Published online by Cambridge University Press: 16 April 2020
Abstract
Cardiovascular diseases represent the most important cause of morbimortality in Portugal. Individuals with severe mental disease have a higher risk of morbidity and mortality related with coronary disease. This is the principal cause of death of psychiatric patients and not suicide. The cardiovascular risk is potenciated by the adverse effects of psychodrugs like excessive weight and interference in glucose homeostasis.
To evaluate socio-demographic, clinical, analytical and pharmacologic variables in psychiatric patients and to determine the prevalence of metabolic syndrome.
Descriptive transversal study of hospitalized patients at Sobral Cid Hospital, random chosen from hospitalized acute and chronic patients.
In a total of 51 individuals, 88.2% were male, 21.6% have between 40 and 50 years old (mean- 50.5 years), without known cardiac disease (92.2%), without tobacco (58.8%), alcohol (74.5%) or other substances consumer (92.2%), having 13.7% diabetes mellitus and 31.4% hypertension. The diagnostic group most prevalent was Schizophrenia, schizotypal and delusional disorders. The following parameters were determined: abdominal obesity (15.75), hypertrygliceridemia (25.5%), low HDL (70.6%), arterial hypertension (41.2%), high level of glycaemia (13.7%), elevated PCR (35.3%), BMI superior or equal to 25 (56.9%) and metabolic syndrome (19.6%). In relation to therapeutics 45.1% were medicated with antidepressives and 76.5% with antipsychotics (47.1% with atypicals).
It is fundamental that the assistant psychiatry identifies and orients patients with cardiovascular risk systematically, and also take into account those parameters when prescribing psychodrugs.
- Type
- Poster Session III: Miscellaneous
- Information
- European Psychiatry , Volume 23 , Issue S2: 16th AEP Congress - Abstract book - 16th AEP Congress , April 2008 , pp. S396
- Copyright
- Copyright © European Psychiatric Association 2008
Comments
No Comments have been published for this article.